MiPS is a urine test for detecting two prostate cancer biomarkers: a piece of RNA made from the prostate cancer antigen 3 (PCA3), and another RNA marker that is found only when TMPRSS2 and ERG abnormally fuse (T2:ERG) [96]. This evidence concerns the gene ERG and prostate carcinoma.